# Renaissance Lakewood, LLC, Lakewood, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/renaissance-lakewood-llc/8b2036d4-96e6-4cb1-84fc-6baf5111e9f7

> Inspection records and compliance data for Renaissance Lakewood, LLC in Lakewood, New Jersey. 14 FDA inspections on record (1 OAI), 4 Form 483s, last inspected July 29, 2026.

---

## Details

- Name: Renaissance Lakewood, LLC
- FEI Number: 2242829
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 1200 Paco Way
- City: Lakewood
- State: New Jersey
- Zip Code: 08701
- Country Name: United States
- Address: 1200 Paco Way, Lakewood, New Jersey 08701, United States
- Country: United States

## Related Documents

- [483 - Renaissance Lakewood, LLC - 2026-07-29](https://www.keypedia.com/records/483/renaissance-lakewood-llc/29ce4e49-4b8f-4753-a930-9ff9e8049263) — source: FDA, date: July 29, 2026
- [FDA Inspection 1327338 - Renaissance Lakewood, LLC - 2026-07-29](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/2d7ee2bf-cbce-4ea9-b434-a1c6bb1c270f) — source: FDA, date: July 29, 2026
- [483 - Renaissance Lakewood, LLC - 2023-06-06](https://www.keypedia.com/records/483/renaissance-lakewood-llc/a205d385-4bcf-413f-bf08-4e99a0204006) — source: FDA, date: June 6, 2023
- [FDA Inspection 1209603 - Renaissance Lakewood, LLC - 2023-06-06](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/ac2a4a96-faa1-4646-8e85-9356b6bc5818) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2023
- [EIR - Renaissance Lakewood, LLC - 2023-05-24](https://www.keypedia.com/records/eir/renaissance-lakewood-llc/a925c3d5-bd03-4755-8d8d-7268ad2a728a) — source: FDA, date: May 24, 2023
- [483 - Renaissance Lakewood, LLC - 2019-08-22](https://www.keypedia.com/records/483/renaissance-lakewood-llc/d4e56ad2-5db7-4135-b99a-37d54cbb6d30) — source: FDA, date: August 22, 2019
- [FDA Inspection 1100331 - Renaissance Lakewood, LLC - 2019-08-22](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/1926619d-ccab-483b-a3a3-928861282710) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2019
- [FDA Inspection 1045720 - Renaissance Lakewood, LLC - 2018-03-15](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/7fab1ae3-9ee1-411e-b55b-8bc8d33dbf55) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2018
- FDA Inspection 1009890 - Renaissance Lakewood, LLC - 2017-04-26 — classification: No Action Indicated (NAI), source: FDA, date: April 26, 2017
- [FDA Inspection 973346 - Renaissance Lakewood, LLC - 2016-06-01](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/7bcac451-1467-4a67-9a95-cbdc38d10a72) — classification: No Action Indicated (NAI), source: FDA, date: June 1, 2016
- FDA Inspection 911163 - Renaissance Lakewood, LLC - 2015-02-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 6, 2015
- [FDA Inspection 903203 - Renaissance Lakewood, LLC - 2014-11-04](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/66351f1e-299f-45c9-864c-77b21092ef04) — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2014
- FDA Inspection 903203 - Renaissance Lakewood, LLC - 2014-11-04 — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2014
- [FDA Inspection 814484 - Renaissance Lakewood, LLC - 2013-01-17](https://www.keypedia.com/records/fda_inspections/renaissance-lakewood-llc/cd57dc04-336b-46a8-aecd-4ce29fc38598) — classification: No Action Indicated (NAI), source: FDA, date: January 17, 2013

## Related Companies

- [Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.](https://www.keypedia.com/companies/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/abed0e84-484c-4ab7-b062-f61cc359a27e)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)
- [Corden Pharma S.p.A.](https://www.keypedia.com/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3)
- [Rottendorf Pharma Gmbh](https://www.keypedia.com/companies/rottendorf-pharma-gmbh/e63a13cc-bb19-4b83-9c26-200b73395eb1)
- [Tris Pharma Inc.](https://www.keypedia.com/companies/tris-pharma-inc/65a6590a-3777-454b-bf0d-a9d37e3bf58e)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [Jerome Stevens Pharmaceuticals, Inc.](https://www.keypedia.com/companies/jerome-stevens-pharmaceuticals-inc/a817cc0c-576c-4b0f-9e89-fdbf69e38686)
- [Ferndale Laboratories, Inc.](https://www.keypedia.com/companies/ferndale-laboratories-inc/0c6013f2-a6e7-41ff-a461-1e3fda056678)
- [Ferring Production Inc.](https://www.keypedia.com/companies/ferring-production-inc/630420f9-f163-4b8d-91f5-d4922708508e)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)

## Related Officers

- [Russell J. Glapion](https://www.keypedia.com/people/russell-j-glapion/54dd6274-563a-44fe-8016-2ebd700be7a0)
- [Director of Investigations Branch](https://www.keypedia.com/people/nerizza-guerin/407df995-bd23-4948-82c2-e3bf8a6659b7)
- [company_representative](https://www.keypedia.com/people/serge-maltais/e15b2fcc-5f9e-4625-8c4d-8ce5ed5c5c01)
- [Investigator](https://www.keypedia.com/people/karishma-g-gopaul/ec5be791-b76c-4a31-bbed-9395e576d2c3)
- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)